GABA-transaminase deficiency |
ABAT |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✗ |
Ichthyosis |
ABCA12 |
16 |
0.00670017 |
0.0133106 |
0.000177171 |
✓ |
Retinal dystrophy |
ABCA4 |
53 |
0.0221943 |
0.0434034 |
0.00188386 |
✓ |
Pseudoxanthoma elasticum |
ABCC6 |
11 |
0.00460637 |
0.00917029 |
0.0000841 |
✓ |
Hyperinsulinism |
ABCC8 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Sitosterolemia 1 |
ABCG8 |
10 |
0.0041876 |
0.00834014 |
0.0000696 |
✓ |
Isobutyryl-CoA dehydrogenase deficiency |
ACAD8 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Acyl-CoA dehydrogenase |
ACADM |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Short-chain acyl-CoA-dehydrogenase deficiency |
ACADS |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
Inborn error of metabolism |
ACADSB |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Very long chain acyl-CoA dehydrogenase deficiency |
ACADVL |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Optic atrophy 9 |
ACO2 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Adenosine deaminase deficiency |
ADA |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Sneddon syndrome |
ADA2 |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
Reduced expression |
ADAMTS13 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Weill-Marchesani syndrome |
ADAMTS17 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Microcornea, myopic chorioretinal atrophy and telecanthus |
ADAMTS18 |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Deafness, non-syndromic, autosomal recessive |
ADGRV1 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Sengers syndrome |
AGK |
6 |
0.00251256 |
0.0050125 |
0.0000251 |
✓ |
Glycogen storage disease 3 |
AGL |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Congenital myasthenic syndrome with distal muscle weakness & atrophy |
AGRN |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Hyperoxaluria |
AGXT |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
Joubert syndrome |
AHI1 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Leber congenital amaurosis IV |
AIPL1 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Autoimmune polyendocrinopathy syndrome |
AIRE |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Bile acid synthesis defect |
AKR1D1 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Sjogren-Larsson syndrome |
ALDH3A2 |
15 |
0.00628141 |
0.0124839 |
0.000155848 |
✓ |
Epilepsy |
ALDH7A1 |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Fructose intolerance |
ALDOB |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
Congenital disorder of glycosylation |
ALG1 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Congenital disorder of glycosylation 1i |
ALG2 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Congenital disorder of glycosylation |
ALG3 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Congenital disorder of glycosylation 1h |
ALG8 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Alstrom syndrome |
ALMS1 |
6 |
0.00251256 |
0.0050125 |
0.0000251 |
✓ |
Odontohypophosphatasia |
ALPL |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
Cerebellar ataxia 3 |
ANO10 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Muscular dystrophy, limb girdle 2L |
ANO5 |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
Hyaline fibromatosis syndrome |
ANTXR2 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Spastic paraplegia 52 |
AP4S1 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Ataxia |
APTX |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Metachromatic leukodystrophy |
ARSA |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Mucopolysaccharidosis type VI (Maroteaux-Lamy) |
ARSB |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Spinal muscular atrophy with progressive myoclonic epilepsy |
ASAH1 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Argininosuccinic aciduria |
ASL |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Microcephaly 5 |
ASPM |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Ataxia-telangiectasia |
ATM |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
Kufor-Rakeb syndrome |
ATP13A2 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Autism spectrum disorder |
ATP2A1 |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
Wilson disease |
ATP7B |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
Neurodevelopmental disorder with poor growth and behavioral abnormalities |
ATP9A |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Pulmonary fibrosis / aplastic anaemia |
ATR |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Nephrotic syndrome |
AVIL |
7 |
0.00293132 |
0.00584546 |
0.0000342 |
✓ |
Muscular dystrophy-dystroglycanopathy |
B3GALNT2 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Spondyloepimetaphyseal dysplasia with joint laxity |
B3GALT6 |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Multiple joint dislocations |
B3GAT3 |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
Peters-Plus syndrome |
B3GLCT |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Spastic paraplegia |
B4GALNT1 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Phenotype modifier |
BBS5 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Bardet-Biedl syndrome, modifier of |
BBS7 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Retinitis pigmentosa |
BBS9 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Butyrylcholinesterase deficiency |
BCHE |
29 |
0.0121441 |
0.0239932 |
0.000575671 |
✓ |
GRACILE syndrome |
BCS1L |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Breast cancer |
BLM |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Biotinidase deficiency |
BTD |
17 |
0.00711893 |
0.0141365 |
0.000199841 |
✓ |
Autism spectrum disorder |
C2CD3 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Complement C5 deficiency |
C5 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Inflammatory bowel disease, very early onset |
C6 |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
Alzheimer disease in Han Chinese, association with |
C7 |
6 |
0.00251256 |
0.0050125 |
0.0000251 |
✓ |
Complement C8 alpha-gamma deficiency |
C8A |
6 |
0.00251256 |
0.0050125 |
0.0000251 |
✓ |
Primary immunodeficiency disease |
C8B |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Carbonic anhydrase VA deficiency |
CA5A |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
Retinal dystrophy |
CABP4 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Muscular dystrophy, limb girdle 2A |
CAPN3 |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
Homocystinuria |
CBS |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Primary ciliary dyskinesia |
CCDC103 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Primary ciliary dyskinesia |
CCDC39 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Primary ciliary dyskinesia |
CCDC40 |
8 |
0.00335008 |
0.00667772 |
0.0000446 |
✓ |
Pseudorheumatoid dysplasia, progressive |
CCN6 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Ciliary dyskinesia |
CCNO |
7 |
0.00293132 |
0.00584546 |
0.0000342 |
✓ |
Platelet glycoprotein IV deficiency |
CD36 |
41 |
0.0171692 |
0.0337488 |
0.00113898 |
✓ |
Usher syndrome |
CDH23 |
11 |
0.00460637 |
0.00917029 |
0.0000841 |
✓ |
Hypotrichosis |
CDH3 |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Autism spectrum disorder |
CDK5RAP2 |
7 |
0.00293132 |
0.00584546 |
0.0000342 |
✓ |
Intellectual disability |
CENPJ |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Seckel syndrome |
CEP152 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Leber congenital amaurosis 10 |
CEP290 |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
Ichthyosis |
CERS3 |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Retinitis pigmentosa |
CFAP410 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Dextrocardia and situs disturbances |
CFAP53 |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Cystic fibrosis |
CFTR |
8 |
0.00335008 |
0.00667772 |
0.0000446 |
✓ |
Congenital myasthenic syndrome |
CHRNE |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Multiple pterygium syndrome |
CHRNG |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Bartter syndrome |
CLCNKB |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Congenital short-bowel syndrome |
CLMP |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Retinal dystrophy, early-onset |
CLN3 |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Achromatopsia 2 |
CNGA3 |
6 |
0.00251256 |
0.0050125 |
0.0000251 |
✓ |
Achromatopsia 3 |
CNGB3 |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
Hypogonadotropic hypogonadism |
CNTN2 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Hypomyelinating neuropathy |
CNTNAP1 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Schizophrenia |
COG7 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Epithelial recurrent erosion dystrophy |
COL17A1 |
7 |
0.00293132 |
0.00584546 |
0.0000342 |
✓ |
Knobloch syndrome |
COL18A1 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Steel syndrome |
COL27A1 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Bethlem myopathy 1 |
COL6A2 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
EBD |
COL7A1 |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Primary coenzyme Q10 deficiency, neonatal onset |
COQ9 |
8 |
0.00335008 |
0.00667772 |
0.0000446 |
✓ |
Haemophagocytic lymphohistiocytosis |
CORO1A |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Hypertrophic cardiomyopathy, early onset |
COX15 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Dysarthria, ataxia and sensory neuropathy |
COX20 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Joubert syndrome |
CPLANE1 |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
Leber congenital amaurosis 8 |
CRB1 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Congenital nephrosis, Finnish type-like, with cerebral ventriculomegaly & raised alpha-fetoprotein |
CRB2 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Short stature, microcephaly & dysmorphic facies |
CRIPT |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Cystinosis |
CTNS |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Pycnodysostosis |
CTSK |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Albuminuria, association with |
CUBN |
52 |
0.0217755 |
0.0426027 |
0.00181499 |
✓ |
3-M syndrome 1 |
CUL7 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Steroid-11 beta-hydroxylase deficiency |
CYP11B1 |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
Glaucoma 3A |
CYP1B1 |
27 |
0.0113065 |
0.0223574 |
0.000499853 |
✓ |
Hyperandrogenism |
CYP21A2 |
135 |
0.0565327 |
0.106673 |
0.0113792 |
✓ |
Cerebrotendinous xanthomatosis |
CYP27A1 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Retinitis pigmentosa |
CYP4V2 |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Leukoencephalopathy with brainstem & spinal cord involvement |
DARS2 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Diarrhea |
DGAT1 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Portal hypertension |
DGUOK |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Miller syndrome |
DHODH |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Congenital scoliosis |
DLL3 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Neural tube defects |
DNAAF1 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Ciliary dyskinesia |
DNAH11 |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Primary ciliary dyskinesia |
DNAH5 |
6 |
0.00251256 |
0.0050125 |
0.0000251 |
✓ |
Situs inversus and male infertility |
DNAH9 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Systemic lupus erythematosus 16 |
DNASE1L3 |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
Adams-Oliver syndrome 2 |
DOCK6 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Immunodeficiency, primary |
DOCK8 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Fetal akinesia deformation sequence 3 |
DOK7 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Microcephaly |
DONSON |
23 |
0.00963149 |
0.0190775 |
0.000363949 |
✓ |
Congenital disorder of glycosylation 1 |
DPAGT1 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Dihydropyrimidine dehydrogenase deficiency |
DPYD |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
Dihydropyrimidinase deficiency |
DPYS |
8 |
0.00335008 |
0.00667772 |
0.0000446 |
✓ |
Cardiomyopathy, arrhythmogenic right ventricular |
DSP |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Hypothyroidism |
DUOX2 |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
Asphyxiating thoracic dystrophy |
DYNC2H1 |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
Short-rib thoracic dysplasia 8 with or without polydactyly |
DYNC2I1 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Arthrogryposis |
ECEL1 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Short-chain enoyl-CoA hydratase deficiency |
ECHS1 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Ectodermal dysplasia 11A |
EDARADD |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Autism spectrum disorder |
ELP1 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Vici syndrome |
EPG5 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Basal cell carcinoma, reduced risk, association with |
ERCC2 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Hearing loss |
ESPN |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Ellis-van Creveld syndrome |
EVC2 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Pontocerebellar hypoplasia 1 |
EXOSC3 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Epidermolysis bullosa, junctional |
EXPH5 |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Retinitis pigmentosa |
EYS |
15 |
0.00628141 |
0.0124839 |
0.000155848 |
✓ |
Factor XI deficiency |
F11 |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
Thrombophilia 1 due to thrombin defect |
F2 |
22 |
0.00921273 |
0.0182557 |
0.000333271 |
✓ |
Factor VII deficiency |
F7 |
18 |
0.00753769 |
0.0149617 |
0.000223854 |
✓ |
Spastic paraplegia 35 |
FA2H |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Tyrosinemia |
FAH |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
Retinitis pigmentosa |
FAM161A |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Fanconi anemia |
FANCC |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Fructose-1,6-bisphosphatase deficiency |
FBP1 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Parkinsonism, juvenile |
FBXO7 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Multiple leiomyomatosis |
FH |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Amyotrophic lateral sclerosis, sporadic |
FIG4 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Posterior column ataxia & retinitis pigmentosa |
FLVCR1 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Complex I deficiency |
FOXRED1 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Congenital anomalies of the kidney and urinary tract |
FRAS1 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Intellectual disability, developmental delay & seizures |
FRRS1L |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Formiminoglutamic acidura |
FTCD |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Glycogen storage disease Ia |
G6PC1 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Glycogen storage disease II |
GAA |
10 |
0.0041876 |
0.00834014 |
0.0000696 |
✓ |
Krabbe disease |
GALC |
7 |
0.00293132 |
0.00584546 |
0.0000342 |
✓ |
Galactokinase deficiency, presenile cataract |
GALK1 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Mucopolysaccharidosis IVA |
GALNS |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Tumoral calcinosis |
GALNT3 |
16 |
0.00670017 |
0.0133106 |
0.000177171 |
✓ |
Cerebral creatine deficiency syndrome 2 |
GAMT |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Gaucher disease |
GBA |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
Spastic paraplegia |
GBA2 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Glycogen storage disease 4 |
GBE1 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Glutaric acidaemia 1 |
GCDH |
6 |
0.00251256 |
0.0050125 |
0.0000251 |
✓ |
Charcot-Marie-Tooth disease |
GDAP1 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Congenital myasthenic syndrome |
GFPT1 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Hypogonadotropic hypogonadism |
GHR |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Hearing loss, non-syndromic |
GIPC3 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Keratoderma |
GJB2 |
30 |
0.0125628 |
0.02481 |
0.000615535 |
✓ |
GM1-gangliosidosis |
GLB1 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Glycine encephalopathy |
GLDC |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
GNE myopathy |
GNE |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
Mucolipidosis III alpha/beta |
GNPTAB |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Hypogonadotropic hypogonadism |
GNRHR |
7 |
0.00293132 |
0.00584546 |
0.0000342 |
✓ |
Absence of collagen-induced platelet activation |
GP6 |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
Hyperekplexia |
GPHN |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Autism spectrum disorder |
GPR179 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Hyperoxaluria II |
GRHPR |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Congenital stationary night blindness |
GRM6 |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
Glycogen storage disease 0 |
GYS2 |
7 |
0.00293132 |
0.00584546 |
0.0000342 |
✓ |
Mitochondrial trifunctional protein deficiency |
HADHB |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Haemoglobin variant |
HBA1 |
34 |
0.0142379 |
0.0280703 |
0.000787941 |
✓ |
Haemoglobin variant |
HBA2 |
22 |
0.00921273 |
0.0182557 |
0.000333271 |
✓ |
Haemoglobin variant |
HBB |
121 |
0.05067 |
0.0962051 |
0.00925543 |
✓ |
Haemoglobin variant |
HBD |
31 |
0.0129816 |
0.0256261 |
0.000656697 |
✓ |
[Hex A pseudodeficiency] |
HEXA |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Alkaptonuria |
HGD |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Mucopolysaccharidosis type IIIC (Sanfilippo C) |
HGSNAT |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Hermansky-Pudlak syndrome 3 |
HPS3 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Apparent mineralocorticoid excess |
HSD11B2 |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Pseudohermaphroditism, male |
HSD17B3 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
D-bifunctional protein deficiency |
HSD17B4 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Scoliosis, idiopathic, association with |
HSPG2 |
14 |
0.00586265 |
0.0116566 |
0.000135875 |
✓ |
Hurler syndrome |
IDUA |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Leber congenital amaurosis |
IFT140 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Mycobacterial infection |
IL12RB1 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
IL-17RA deficiency with bacterial and fungal infections |
IL17RA |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
Joubert syndrome 1 |
INPP5E |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Leber congenital amaurosis |
IQCB1 |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Leukocyte adhesion deficiency |
ITGB2 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Bleeding disorder |
ITGB3 |
15 |
0.00628141 |
0.0124839 |
0.000155848 |
✓ |
Hirschsprung disease |
ITGB4 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Isovaleric acidemia |
IVD |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Hypothyroidism |
IYD |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Immunodeficiency, severe combined |
JAK3 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Bartter syndrome |
KCNJ1 |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
Retinal cone dystrophy 3B |
KCNV2 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Joubert syndrome |
KIAA0586 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Cerebellar ataxia |
KIF1C |
10 |
0.0041876 |
0.00834014 |
0.0000696 |
✓ |
Macrocephaly, multiple epiphyseal dysplasia & facial features |
KIF7 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Retinitis pigmentosa 42 |
KLHL7 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Schizophrenia |
LAMA1 |
9 |
0.00376884 |
0.00750928 |
0.0000564 |
✓ |
Epidermolysis bullosa, junctional |
LAMA3 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Pierson syndrome/ nephrotic syndrome type 5 |
LAMB2 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Epidermolysis bullosa, Herlitz |
LAMC2 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
LDL cholesterol level QTL2 |
LDLR |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Hypopituitarism and sensorineural hearing loss |
LHX3 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome |
LIFR |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Marfan syndrome, early-onset |
LIG4 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Intellectual developmental disorder |
LINS1 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Factor V and factor VIII deficiency, combined |
LMAN1 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Triphalangeal thumbs and preaxial polydactyly |
LMBR1 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Mandibuloacral dysplasia |
LMNA |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Deafness |
LOXHD1 |
6 |
0.00251256 |
0.0050125 |
0.0000251 |
✓ |
Myopia 28 |
LOXL3 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Hyperlipidaemia |
LPL |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Infantile mitochondrial disease, lethal |
LRPPRC |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Osteosclerotic metaphyseal dysplasia |
LRRK1 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Chediak-Higashi syndrome |
LYST |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Immunodeficiency, combined |
MALT1 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Nephronophthisis, late onset |
MAPKBP1 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Ciliary dyskinesia |
MCIDAS |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Neutrophilic dermatosis |
MEFV |
73 |
0.0305695 |
0.05927 |
0.00351294 |
✓ |
Parkinson disease, early onset |
MKS1 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Methylmalonic aciduria and homocystinuria |
MMACHC |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Homocystinuria, cblD type |
MMADHC |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Methylmalonic aciduria |
MMUT |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Thiopurine-induced toxicity |
MOCOS |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Thrombocytosis, association with |
MPL |
9 |
0.00376884 |
0.00750928 |
0.0000564 |
✓ |
Trichothiodystrophy, nonphotosensitive |
MPLKIP |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Mitochondrial DNA depletion syndrome, hepatocerebral |
MPV17 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Breast cancer |
MRE11 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Cleft lip with or without cleft palate |
MTRR |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Hyper-IgD syndrome |
MVK |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
Deafness, non-syndromic, autosomal recessive |
MYO15A |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Diarrhea 2 |
MYO5B |
6 |
0.00251256 |
0.0050125 |
0.0000251 |
✓ |
Bone, connective tissue, liver, immune system & retinal defects |
NBAS |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Breast cancer, male |
NBN |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Chronic granulomatous disease |
NCF1 |
8 |
0.00335008 |
0.00667772 |
0.0000446 |
✓ |
Chronic granulomatous disease |
NCF2 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Leigh syndrome/Mitochondrial Complex I deficiency |
NDUFAF5 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Neurodevelopmental disorder |
NDUFS1 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Amyotrophic lateral sclerosis |
NEK1 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Renal disease with hepatic and cardiac anomalies |
NEK8 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Spastic ataxia 8 |
NKX6-2 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Nephronophthisis 1 |
NPHP1 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Nephronophthisis 4 |
NPHP4 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Nephrotic syndrome |
NPHS1 |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Retinitis pigmentosa 37 |
NR2E3 |
7 |
0.00293132 |
0.00584546 |
0.0000342 |
✓ |
Complex I deficiency |
NUBPL |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Cardiomyopathy, dilated |
OBSL1 |
7 |
0.00293132 |
0.00584546 |
0.0000342 |
✓ |
Pseudo-TORCH syndrome 1 |
OCLN |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Optic atrophy plus syndrome |
OPA1 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Lymphoproliferative disorder |
ORC4 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Meier-Gorlin syndrome |
ORC6 |
6 |
0.00251256 |
0.0050125 |
0.0000251 |
✓ |
Hearing loss |
OTOA |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Deafness, non-syndromic |
OTOF |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Hearing loss, sensorineural |
OTOG |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Hearing impairment |
OTOGL |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
Hyperphenylalaninemia |
PAH |
40 |
0.0167504 |
0.0329397 |
0.00108502 |
✓ |
Neurodegeneration with brain iron accumulation 1 |
PANK2 |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
Hyperinsulinism |
PC |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Retinitis pigmentosa 54 |
PCARE |
8 |
0.00335008 |
0.00667772 |
0.0000446 |
✓ |
Propionicacidemia |
PCCB |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Usher syndrome 1 |
PCDH15 |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
Retinitis pigmentosa, pericentral |
PDE6B |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Tourette syndrome |
PDP1 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Prolidase deficiency |
PEPD |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Zellweger syndrome |
PEX1 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Peroxisome biogenesis disorder 3B |
PEX12 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Peroxisome biogenesis disorder 8B |
PEX16 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Refsum disease, infantile |
PEX26 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Peroxisome biogenesis disorder 4B |
PEX6 |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Congenital disorder of glycosylation |
PGM1 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Fetal alcohol syndrome, predisposition to |
PGM3 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Primary microcephaly |
PHC1 |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Neu-Laxova syndrome 1 |
PHGDH |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
PIGO deficiency |
PIGO |
7 |
0.00293132 |
0.00584546 |
0.0000342 |
✓ |
Deafness |
PJVK |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
Polycystic kidney disease 4 |
PKHD1 |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
Pyruvate kinase deficiency |
PKLR |
18 |
0.00753769 |
0.0149617 |
0.000223854 |
✓ |
Infantile neuroaxonal dystrophy |
PLA2G6 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Myopathy |
PLEKHG5 |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Ehlers-Danlos syndrome |
PLOD1 |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
Congenital disorder of glycosylation 1a |
PMM2 |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Nucleoside phosphorylase deficiency |
PNP |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Pyridoxamine 5'-phosphate oxidase deficiency |
PNPO |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Mitochondrial recessive ataxia syndrome |
POLG |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Altered function |
POR |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Camptodactyly-arthropathy-coxa vara-pericarditis syndrome |
PRG4 |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
Neural tube defects |
PRICKLE1 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Thrombophilia 3 due to protein C deficiency |
PROC |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Hypotonia, microcephaly and global developmental delay |
PRUNE1 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Combined SAP deficiency |
PSAP |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
Developmental disorder |
PSAT1 |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Congenital sensorineural hearing loss, autosomal recessive |
PTPRQ |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
Tetrahydrobiopterin deficiency |
PTS |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Glycogen storage disease 6 |
PYGL |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
McArdle disease |
PYGM |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Microcephaly |
QARS1 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Dihydropteridine reductase deficiency |
QDPR |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Microphthalmia & cataract |
RAB3GAP2 |
10 |
0.0041876 |
0.00834014 |
0.0000696 |
✓ |
Omenn syndrome |
RAG1 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Congenital myasthenic syndrome |
RAPSN |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Pulmonary arterial hypertension |
RARS2 |
7 |
0.00293132 |
0.00584546 |
0.0000342 |
✓ |
Microphthalmia |
RAX |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Baller-Gerold syndrome |
RECQL4 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
MHC class II deficiency |
RFXANK |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Aicardi-Goutieres syndrome 4 |
RNASEH2A |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Aicardi-Goutières syndrome |
RNASEH2B |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Aicardi-Goutieres syndrome 3 |
RNASEH2C |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Gaze palsy |
ROBO3 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Kohlschütter-Tönz syndrome |
ROGDI |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Cone-rod dystrophy 13 |
RPGRIP1 |
11 |
0.00460637 |
0.00917029 |
0.0000841 |
✓ |
Primary microcephaly & primordial dwarfism |
RTTN |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Congenital myopathy 1B |
RYR1 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Spastic ataxia, Charlevoix-Saguenay |
SACS |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Retinitis pigmentosa, autosomal recessive |
SAG |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Shwachman-Diamond syndrome |
SBDS |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
Charcot-Marie-Tooth disease |
SBF1 |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Paramyotonia congenita |
SCN4A |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Childhood absence epilepsy |
SCN9A |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Anaemia, dyserythropoietic congenital, type II |
SEC23B |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Cerebellar atrophy |
SEPSECS |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Reduced alpha-1-antitrypsin concentration |
SERPINA1 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Osteogenesis imperfecta |
SERPINF1 |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Muscular dystrophy |
SGCD |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Muscular dystrophy, limb girdle |
SGCG |
32 |
0.0134003 |
0.0264415 |
0.000699155 |
✓ |
Mucopolysaccharidosis type IIIA (Sanfilippo A) |
SGSH |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Sucrase isomaltase deficiency |
SI |
7 |
0.00293132 |
0.00584546 |
0.0000342 |
✓ |
Macular degeneration, age related, reduced risk |
SKIV2L |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Gitelman syndrome |
SLC12A3 |
8 |
0.00335008 |
0.00667772 |
0.0000446 |
✓ |
Wernicke's-like encephalopathy |
SLC19A3 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Carnitine deficiency |
SLC22A5 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Intrahepatic cholestasis, neonatal |
SLC25A13 |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Thiamine metabolism dysfunction syndrome 4 |
SLC25A19 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Carnitine-acylcarnitine translocase deficiency |
SLC25A20 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Deafness |
SLC26A4 |
19 |
0.00795645 |
0.0157863 |
0.000249207 |
✓ |
Glucose transporter type 1 deficiency syndrome |
SLC2A1 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
?Fanconi renotubular syndrome 2 |
SLC34A1 |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Schneckenbecken dysplasia |
SLC35D1 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Glycogen storage disease 1b |
SLC37A4 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Foveal hypoplasia, optic nerve decussation defects and anterior segment dysgenesis |
SLC38A8 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
?Hyperostosis cranalis interna |
SLC39A14 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Cystinuria |
SLC3A1 |
6 |
0.00251256 |
0.0050125 |
0.0000251 |
✓ |
Neuronopathy |
SLC5A7 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Hartnup disorder |
SLC6A19 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Niemann-Pick disease |
SMPD1 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Neuronopathy, distal hereditary motor, autosomal recessive 8 |
SORD |
12 |
0.00502513 |
0.00999975 |
0.0001 |
✓ |
Leber congenital amaurosis 3 |
SPATA7 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Charcot-Marie-Tooth disease |
SPG11 |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
Spastic paraplegia |
SPG7 |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
Spherocytosis |
SPTA1 |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
Deafness, non-syndromic |
STRC |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Neurodevelopmental disorder with ataxia |
SVBP |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Ichthyosiform erythroderma, congenital, nonbullous |
TGM1 |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Intellectual disability |
THOC6 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Deafness |
TMC1 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Cerebro-facio-thoracic dysplasia |
TMCO1 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Oral-facial-digital syndrome |
TMEM107 |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Joubert syndrome 16 |
TMEM138 |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
Meckel syndrome |
TMEM231 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Joubert syndrome related disorder |
TMEM237 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Nephronophthisis 11 |
TMEM67 |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
Hearing loss |
TMPRSS3 |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
Hemolytic anemia due to triosephosphate isomerase deficiency |
TPI1 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
Thyroid dyshormonogenesis 2A |
TPO |
15 |
0.00628141 |
0.0124839 |
0.000155848 |
✓ |
Hearing loss |
TPRN |
6 |
0.00251256 |
0.0050125 |
0.0000251 |
✓ |
Hypogonadotropic hypogonadism, normosmic |
TRAPPC9 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Developmental disorder |
TRIOBP |
6 |
0.00251256 |
0.0050125 |
0.0000251 |
✓ |
Spinal muscular atrophy & congenital bone fractures |
TRIP4 |
7 |
0.00293132 |
0.00584546 |
0.0000342 |
✓ |
Neurodevelopmental disorder |
TRMT10A |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Night blindness |
TRPM1 |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Intellectual disability & epilepsy |
TSEN54 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Bardet-Biedl syndrome |
TTC21B |
6 |
0.00251256 |
0.0050125 |
0.0000251 |
✓ |
Fatigue, failure to thrive & diarrhoea |
TTC37 |
7 |
0.00293132 |
0.00584546 |
0.0000342 |
✓ |
Immunodeficiency, combined, with intestinal atresias |
TTC7A |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Muscular dystrophy |
TTN |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Diaphragmatic hernia |
TUBGCP6 |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
Albinism, oculocutaneous |
TYR |
14 |
0.00586265 |
0.0116566 |
0.000135875 |
✓ |
Johanson-Blizzard syndrome |
UBR1 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
?Hip dysplasia |
UFSP2 |
7 |
0.00293132 |
0.00584546 |
0.0000342 |
✓ |
Beta-ureidopropionase deficiency |
UPB1 |
10 |
0.0041876 |
0.00834014 |
0.0000696 |
✓ |
Retinitis Pigmentosa |
USH2A |
13 |
0.00544389 |
0.0108285 |
0.000117256 |
✓ |
Mitochondrial encephalopathy |
VARS2 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Rickets |
VDR |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
Cohen syndrome |
VPS13B |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
Arthrogryposis, renal dysfunction and cholestasis |
VPS33B |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Parkinson disease, early onset |
VPS53 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
von Willebrand disease |
VWF |
9 |
0.00376884 |
0.00750928 |
0.0000564 |
✓ |
Short rib-polydactyly syndrome |
WDR35 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Microcephaly, primary |
WDR62 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Usher syndrome |
WHRN |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Werner syndrome |
WRN |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
NPHP-like kidney disease |
XPNPEP3 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Desbuquois dysplasia 2 |
XYLT1 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
Spastic paraplegia with thin corpus callosum |
ZFYVE26 |
6 |
0.00251256 |
0.0050125 |
0.0000251 |
✓ |